Cyberonics (CYBX) Discusses Profitability and Growth Possibilities in Epilepsy Market
Cyberonics, Inc. (CYBX) presented Wednesday at the Jefferies 2nd Annual Healthcare Conference in New York, NY. The company is a medical technology company with core expertise in neuromodulation. Cyberonics develops and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. This is done by surgically implanting a medical device that delivers pulsed electrical signals to the vagus nerve. The system includes a generator to provide the correct stimulation to the vagus nerve, and there is a lead that runs from the generator to the nerve itself. Dan Moore, president…